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A B S T R A C T
Solitary splenic metastases are very rare and sporadic. There are several explanations for this low incidence of splenic
metastasis including anatomical, histological and immunological features of the spleen. In this paper we present a case
of 70-year-old man with no history of previous diseases who was first operated under the diagnosis of acute abdomen re-
vealing perforated colon tumor of splenic flexure with no metastases at that time. Left hemicolectomy was performed fol-
lowed by postoperative complications demanding a subtotal colectomy and ileostomy. Primary tumor was classified as
Dukes (Astler-Coller)-C2, T4N1M0. Patient was referred to oncologist and received chemotherapy (5FU, Leucovorin). 5
months later continuity of the gut was performed by ileosygmoanastomosis. 2 years after first surgical procedure, a CT
scan and abdominal ultrasound, followed by needle biopsy, showed isolated metastasis in spleen, so splenectomy was
performed. Pathological findings revealed sharply bordered, partially necrotic tumor inside of spleen tissue, spreading
to, but not reaching splenic hilum. Histology showed low to medium differentiated adenocarcinoma tissue with desmo-
plastic stromal reaction. There were no protrusions of tumor cells through spleen surface. In splenic hilum 4 tumor free
lymph nodes were harvested. No additional chemotherapy was conducted. The latest follow up, a year after diagnosis of
metastasis showed no signs of cancer disease. Review of the literature showed that long term survival and prognosis of
isolated splenic colorectal metastasis after splenectomy are rather optimistic, although these are the cases of distant me-
tastasis. Due to small number of cases reported in literature, definitive conclusions and/or guidelines for the treatment of
isolated splenic metastasis cannot be given, but splenectomy and chemotherapy are preferable in the treatment, promis-
ing long term survival at least for metachronous metastasis.
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Introduction
The incidence of splenic metastasis, due to better
medical imaging and long term follow up has been in-
creasing1. In most of the cases, they are part of multivis-
ceral metastatic cancer2. There have been several au-
topsy studies considering prevalence of splenic meta-
stasis ranging from 2.3 to 7.1%3. Also, there have been
several studies considering prevalence in living patients
showing 1.3% of 1280 splenic tumors as metastatic4,
9.8% of 122 diagnostic splenectomies were positive for
metastasis4 and 1% of 1743 splenectomies were positive
for metastasis5.
Majority of the cases are part of multivisceral meta-
static diseases and usually originate from breast, lung,
ovarian, colorectal and gastric cancer and skin mela-
noma3,5. Most of them are asymptomatic and diagnosed
during regular follow up by ultrasound and CT scan,
while PET scan is introduced as tool for revealing more
asymptomatic cases1. Solitary metastases are very rare
and sporadic2. Incidence of colon and rectum metastasis
in autopsy study of Berge3 was 4.4 and 1.6% respectively,
however no solitary metastases were reported. Pisanu et
al.6 reported in their case report and review of the litera-
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ture, published in November 2007, only 42 cases of well
documented isolated splenic metastasis of colon and rec-
tum origin. There are several explanations for this low
incidence of splenic metastasis including anatomical, his-
tological and immunological features of the spleen7.
Case Report
In 2005, a 70-year-old man with no history of previous
diseases was referred to emergency department of our
Clinic suffering from abdominal pain, fatigue and vomit-
ing. During clinical examination distension and tender-
ness of abdomen were found and patient was immedi-
ately operated under the diagnosis of acute abdomen.
Laparoscopic exploration was done at first and it re-
vealed approximately 1 L of free intraperitoneal puss so
conversion to open laparotomy was done. After perito-
neal washing, a perforated tumor (approximately 10´5
cm) of splenic flexure was found, infiltrating surround-
ing fat tissue close to pancreas tail. No macroscopic
metastases were found. Left hemicolectomy was per-
formed with end to end hand sewed anastomosis. On
10th postoperative day patient developed signs of acute
abdomen, so relaparotomy was done revealing anasto-
motic leakage. Since the rest of the colon was distended,
a subtotal colectomy and ileostomy was performed. Two
weeks after the second operation patient was discharged
from hospital.
Pathological finding revealed ulcero-infiltrative cir-
cumferential tumor, whose dimension was 11.5´4.5 cm.
Histology analyses showed a moderately differentiated
adenocarcinoma with high mitotic and apoptotic pattern
together with areas of necrosis. Tumor invaded visceral
peritoneum and surrounding fat tissue. Five lymph no-
des were harvested and two of them were positive for me-
tastasis. Resection margins of colon and mesocolon were
free of tumor. Overall, primary tumor was classified as
Dukes-C, Dukes (Astler-Coller)-C2, T4 N1 M0, stage
IIIB, according to TNM system and histological grade –
G2.
Following discharge from surgery department patient
was referred to oncologist and received chemotherapy
(5FU, Leucovorin). Four months after the initial exami-
nation, patient was admitted to our Clinic and continuity
of the gut was performed by ileosygmoanastomosis. The
free edge of sigmoid colon was resected during surgery
and histopathology did not revealed signs of colon cancer.
The patient was regularly followed up, having no symp-
toms of the disease. A scheduled CT scan in May 2007
showed hypovascular lesion of the spleen, 7.9 cm in di-
ameter (Figure 1). Other findings were normal except for
gallbladder stone. CEA level was 5.05 mg/L (ref. <3.4
mg/L). Abdominal ultrasound examination also showed
hypovascular lesion (Figure 2). In July 2007 an ultra-
sound guided needle biopsy was performed and cytology
analyses revealed adenocarcinoma cells. Patient was
again admitted to our Clinic and scheduled for surgery.
Laparotomy was done and exploration revealed spleen
with tumor mass inside with no protrusion through
spleen tissue. There were no signs of other metastatic le-
sions. Splenectomy was performed. Pathology findings
after splenectomy revealed an enlarged spleen (13´10´5
cm) (Figure 3a and 3b) with sharply bordered, partially
necrotic tumor (8´7´3 cm) inside of spleen tissue, sprea-
ding to but not reaching splenic hilum (Figure 4). Histol-
ogy examination showed low to medium differentiated
adenocarcinoma tissue with desmoplastic stromal reac-
tion. There were no protrusions of tumor cells through
spleen surface. In splenic hilum four lymph nodes were
harvested, all without carcinoma cells.
Early postoperative myocardial infarction developed
and stenting of left anterior descending coronary artery
was performed. A week later a cerebrovascular infarction
developed with dysphasia and mild right hemiparesis.
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Fig 1. Abdominal CT scan showing hypovascular splenic lesion.
Fig. 2. Abdominal ultrasound showing hypovascular splenic
lesion.
There were no surgical complications. In August 2007
patient was discharged from hospital and referred to spe-
cialized institution for further rehabilitation. No addi-
tional chemotherapy was conducted. The latest follow up
in May 2008 showed no signs of cancer disease.
Discussion
As mentioned before, splenic metastasis of various
cancers are very rare and usually part of multivisceral
dissemination and isolated metastases are sporadic. The-
re are several theories to explain this rarity and two
main are: first including mechanical/anatomical and his-
tological factors preventing implantation of blood borne
cancer cells. These factors include constant flow of blood
through spleen and rhythmic contractions of splenic cap-
sule and splenic sinusoidal architecture, sharp angle of
splenic and celiac artery preventing clamps of tumor cells
from passing through and lack of afferent lymphatic ves-
sels limiting lymphogenic metastases7,8. According to
Indudhara9 neoplastic cells can reach splenic vein and
parenchyma by retrograde diffusion through the inferior
mesenteric vein. The spleen parenchyma has no lym-
phatic vessels but they are present in capsular, subcap-
sular and trabecular regions8. Tumor cells might also
reach the spleen through lymphatic system which ex-
plains the subcapsular localization of isolated splenic
metastasis8. The second theory includes immunology fac-
tors and that is inhibitory effect of splenic microenvi-
ronment on the growth of cancer cells3,7 as the spleen is
the second largest organ of lymphoreticular endothelial
system, so immune surveillance appears to potentially
inhibit tumor cell proliferation10. However, recent stud-
ies based on sensitive immunologic and molecular meth-
ods that can detect single cells showed that micrometa-
stases can be detected at the time of tumor diagnosis11,12.
Considering this, it could be assumed that implantation
of cancer cells can occur but further growth is inhibited
by microenvironment, explaining high prevalence of
spleen micrometastasis found at autopsy and low preva-
lence of clinically detectable metastases2.
The prevalence of splenic metastasis, although very
low, is increasing with the improvement of imaging tech-
niques2. About 20% of colorectal carcinomas are meta-
static at their clinical presentation13. The usual sites of
metastasis are liver, lung and axial skeleton14,15. Micro-
scopic splenic metastases were found in 7–34% of cancer
patients3. In the same study, incidence of splenic colo-
rectal micrometastasis was reported as 2% of 1019 colo-
rectal tumors but all of these cases involved other organs
as well3. In his article, Pisanu reported that up to his case
review only 41 cases of isolated colorectal splenic metas-
tasis have been reported6 and most of the cases were
metachronous.
Majority of cases reported had a disease free survival
period of 3–144 months after the diagnosis of primary
tumor16–18. Long term survival after splenectomy in pa-
tients with metachronous splenic metastasis was 0.5–7
years17–19. So, prognosis of isolated splenic colorectal me-
tastasis is rather optimistic, although these are the cases
of distant metastasis19. For synchronous metastasis much
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b
Fig 3. a) Spleen without visible tumor protrusion, b) Spleen (hi-
lum) without visible tumor protrusion
Fig. 4. Spleen crossected through hilum.
worse prognosis and shorter disease free survival has
been reported18.
Although due to small number of cases reported in lit-
erature, definitive conclusions and/or guidelines for the
treatment of isolated splenic metastasis can not be given,
splenectomy and chemotherapy are preferable in treat-
ment, promising long term survival, at least for meta-
chronous metastasis.
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IZOLIRANA METASTAZA RAKA DEBELOG CRIJEVA U SLEZENI – PRIKAZ SLU^AJA I PREGLED
LITERATURE
S A @ E T A K
Izolirane metastaze u slezeni javljaju se vrlo rijetko i sporadi~no. Postoji nekoliko obja{njenja ove niske incidencije
metastaza u slezeni, uklju~uju}i anatomske, histolo{ke i imunolo{ke osobine slezene. U ovom ~lanku prezentirali smo
slu~aj 70-godi{njeg mu{karca, koji ranije nije bolovao od te`ih bolesti,a koji je najprije operiran pod klini~kom slikom
akutnog abdomena kada je otkriven perforirani tumor debelog crijeva u podru~ju lijenalne fleksure bez metastaza.
U~injena je lijeva hemikolektomija, a potom zbog poslijeopoeracijskih komplikacija subtotalna kolektomija i isleostoma.
Primarni tumor klasificiran kao Dukes (Astler-Coller)-C2, T4N1M0. Pacijent je upu}en onkologu te je primio kemo-
terapiju (5FU, Leucovorin). Pet mjeseci kasnije kontinuitet probavnog sustava uspostavljen je ileosigmoanastomozom.
Dvije godine nakon prve operacije CT i ultrazvuk trbuha te punkcijska biopsija otkrili su izoliranu metastazu u slezeni
te je u~injena splenektomija. Patolo{ka analiza pokazala je da se radi o o{tro ograni~enom, djelomi~no nekroti~nom
tumoru unutar tkiva slezene koji se {iri prema, ali ne dopire do hilusa slezene. Histolo{ka analiza pokazala je nisko do
srednje diferenciran adenokarcinom sa dezmoplasti~kom rekacijom strome.Nije na|ena protruzija stanica tumora kroz
povr{inu slezene. Iz hilusa slezene izolirana su 4 limfna ~vora bez znakova tumorskog rasta. Dodatna kemoterapija nije
provedena. Na zadnjem kontrolnom pregledu, godinu dana nakon dijagnoze metastaze, kod pacijenta nije na|ena kar-
cinomska bolest. Pregled literature ukazuje da je dugoro~no pre`ivljavanje bolesnika sa izoliranim metastazama raka
debelog crijeva u slezeni nakon splenektomije mogu}e te prognoza prili~no optimisti~na, iako su to zapravo slu~ajevi
udaljenih metastaza. Zbog malog broja slu~ajeva opisanih u literaturi, definitivni zaklju~ci i/ili smjernice za lije~enje
izoliranih metastaza raka debelog crijeva u slezeni ne mogu se donijeti ali su splenektomija i kemoterapija preporu~ljivi
na~ini lije~enja obe}avaju}i dugoro~no pre`ivljenje, barem kod metakronih metastaza.
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